Histiocytosis patient registry for Erdheim-Chester and related diseases
Part of Blood & lymphatic, Lungs & breathing clinical trials.
This is a registry (a research database) for people with Erdheim-Chester disease and other related “histiocytosis” conditions. It collects past and future medical information to better understand these illnesses and support future research.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be diagnosed with Erdheim-Chester disease or a related histiocytosis (such as Langerhans cell histiocytosis or Rosai-Dorfman disease)
- Your diagnosis must be supported by medical records (pathology biopsy results, imaging tests, or other supporting documentation)
- You must be at least 18 years old
- You need to be willing to sign the study consent
- You must agree to let the registry collect and review your health records now and in the future
- You need to be comfortable with English for study communication
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is checking in over time with people who have a histiocytic disorder. It may help doctors better understand how these conditions behave and what follow-up care works best.
This study looks at what support caregivers of people with Erdheim-Chester disease and related rare conditions need. It may help improve caregiver support so families cope better while the patient is being treated.
This trial is a worldwide registry that collects basic medical information from people diagnosed with Castleman disease. It helps researchers learn about real-world care and outcomes across different ages and care settings.
This is a study that enrolls people who have early or unclear signs of an autoimmune connective tissue problem. It aims to better understand these conditions over time, which may help future diagnosis and treatment planning.
This study collects information from patients with Erdheim-Chester disease (ECD) to better understand the condition and how it is treated. By looking at medical records, researchers hope to improve care for people with ECD.
This study is a registry that collects information about people diagnosed with rare histiocytic disorders. It helps doctors better understand these conditions over time and may improve future care.
Hear when a new Erdheim-Chester Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.